News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
842,854 Results
Type
Article (77954)
Company Profile (726)
Press Release (764152)
Multimedia
Podcasts (187)
Webinars (28)
Section
Business (227707)
Career Advice (3839)
Deals (39431)
Drug Delivery (151)
Drug Development (89773)
Employer Resources (205)
FDA (18138)
Job Trends (17203)
News (388964)
Policy (39104)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (3013)
Academic (1)
Accelerated approval (34)
Adcomms (36)
Allergies (149)
Alliances (56501)
ALS (181)
Alzheimer's disease (1798)
Antibody-drug conjugate (ADC) (351)
Approvals (18322)
Artificial intelligence (584)
Autoimmune disease (166)
Automation (38)
Bankruptcy (404)
Best Places to Work (12633)
BIOSECURE Act (23)
Biosimilars (204)
Biotechnology (447)
Bladder cancer (164)
Brain cancer (65)
Breast cancer (668)
Cancer (5070)
Cardiovascular disease (450)
Career advice (3292)
Career pathing (41)
CAR-T (306)
CDC (59)
Celiac Disease (2)
Cell therapy (817)
Cervical cancer (38)
Clinical research (75833)
Collaboration (1843)
Company closure (4)
Compensation (1176)
Complete response letters (73)
COVID-19 (2993)
CRISPR (99)
C-suite (882)
Cystic fibrosis (155)
Data (6332)
Decentralized trials (2)
Denatured (67)
Depression (151)
Diabetes (535)
Diagnostics (7235)
Digital health (46)
Diversity (13)
Diversity, equity & inclusion (49)
Drug discovery (275)
Drug pricing (226)
Drug shortages (36)
Duchenne muscular dystrophy (241)
Earnings (96918)
Editorial (65)
Employer branding (25)
Employer resources (173)
Events (133975)
Executive appointments (1034)
FDA (21347)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1558)
Gene editing (217)
Generative AI (54)
Gene therapy (666)
GLP-1 (1139)
Government (5418)
Grass and pollen (8)
Guidances (387)
Healthcare (20935)
HIV (63)
Huntington's disease (50)
IgA nephropathy (86)
Immunology and inflammation (296)
Immuno-oncology (62)
Indications (104)
Infectious disease (3282)
Inflammatory bowel disease (206)
Inflation Reduction Act (17)
Influenza (120)
Intellectual property (251)
Interviews (745)
IPO (17860)
IRA (60)
Job creations (4974)
Job search strategy (2666)
JPM (70)
Kidney cancer (16)
Labor market (94)
Layoffs (655)
Leadership (40)
Legal (10017)
Liver cancer (99)
Longevity (15)
Lung cancer (682)
Lymphoma (382)
Machine learning (44)
Management (66)
Manufacturing (850)
MASH (175)
Medical device (15019)
Medtech (15075)
Mergers & acquisitions (22645)
Metabolic disorders (1412)
Multiple sclerosis (165)
NASH (23)
Neurodegenerative disease (356)
Neuropsychiatric disorders (103)
Neuroscience (3130)
Neurotech (1)
NextGen: Class of 2026 (7662)
Non-profit (5110)
Now hiring (66)
Obesity (688)
Opinion (336)
Ovarian cancer (168)
Pain (216)
Pancreatic cancer (234)
Parkinson's disease (301)
Partnered (36)
Patents (511)
Patient recruitment (493)
Peanut (60)
People (65518)
Pharmaceutical (134)
Pharmacy benefit managers (33)
Phase 1 (23466)
Phase 2 (33031)
Phase 3 (24904)
Pipeline (5239)
Policy (339)
Postmarket research (3304)
Preclinical (10331)
Press Release (72)
Prostate cancer (250)
Psychedelics (57)
Radiopharmaceuticals (302)
Rare diseases (926)
Real estate (7186)
Recruiting (80)
Regulatory (28392)
Reports (67)
Research institute (2724)
Resumes & cover letters (599)
Rett syndrome (28)
RNA editing (21)
RSV (85)
Schizophrenia (160)
Series A (261)
Series B (198)
Service/supplier (26)
Sickle cell disease (104)
Special edition (27)
Spinal muscular atrophy (177)
Sponsored (48)
Startups (4230)
State (2)
Stomach cancer (20)
Supply chain (112)
Tariffs (101)
The Weekly (118)
Vaccines (1148)
Venture capital (98)
Weight loss (474)
Women's health (89)
Worklife (22)
Date
Today (39)
Last 7 days (652)
Last 30 days (2523)
Last 365 days (32134)
2026 (3066)
2025 (32525)
2024 (37893)
2023 (42566)
2022 (53928)
2021 (58723)
2020 (57665)
2019 (51314)
2018 (39093)
2017 (36878)
2016 (37797)
2015 (43773)
2014 (38448)
2013 (34526)
2012 (36478)
2011 (36552)
2010 (36019)
Location
Africa (1224)
Alabama (92)
Alaska (7)
Arizona (325)
Arkansas (14)
Asia (49991)
Australia (8594)
California (11642)
Canada (3332)
China (1180)
Colorado (495)
Connecticut (502)
Delaware (348)
Europe (114090)
Florida (1711)
Georgia (375)
Hawaii (4)
Idaho (67)
Illinois (950)
India (69)
Indiana (546)
Iowa (24)
Japan (434)
Kansas (132)
Kentucky (43)
Louisiana (30)
Maine (83)
Maryland (1459)
Massachusetts (8549)
Michigan (352)
Minnesota (666)
Mississippi (6)
Missouri (139)
Montana (35)
Nebraska (29)
Nevada (127)
New Hampshire (85)
New Jersey (3128)
New Mexico (33)
New York (3072)
North Carolina (1612)
North Dakota (10)
Northern California (5589)
Ohio (354)
Oklahoma (23)
Oregon (53)
Pennsylvania (2321)
Puerto Rico (23)
Rhode Island (50)
South America (1594)
South Carolina (67)
South Dakota (1)
Southern California (4499)
Tennessee (176)
Texas (1818)
United States (41862)
Utah (350)
Vermont (1)
Virginia (290)
Washington D.C. (88)
Washington State (979)
West Virginia (4)
Wisconsin (129)
Wyoming (2)
842,854 Results for "co don ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SpliceBio Appoints Don Munoz as Chief Financial Officer
January 6, 2026
·
2 min read
Venture capital
Biotech Markets Turn Positive but Experts Say Don’t Call It a Comeback—Yet
M&A is back, the S&P XBI is rising again, a biotech pulled off an IPO and positive data is pulling in investors again. This may just be the industry’s new normal.
October 22, 2025
·
7 min read
·
Annalee Armstrong
obesity
JPM26: Novartis Doesn’t Have a GLP-1. They Don’t Miss It In a World Of Me-Toos
Speaking to
BioSpace
at the J.P. Morgan Healthcare Conference, Novartis’ chief dealmaker Ronny Gal explains why the Swiss pharma hasn’t acquired a GLP-1, and why it probably won’t.
January 13, 2026
·
3 min read
·
Annalee Armstrong
Press Releases
OSR Holdings Appoints Scientific Co-Founder Dr. Andreas Niethammer as Chief Executive Officer of Vaximm AG to Lead Next Phase of Immuno-Oncology Expansion
November 17, 2025
·
3 min read
Press Releases
Tenacia Biopharmaceuticals and Golden Age Health Partner to Commercialize ZTALMY® for CDKL5 Deficiency Disorder in Mainland China
February 2, 2026
·
3 min read
Press Releases
vTv Therapeutics Amends License Agreement with Newsoara Biopharma Co. Ltd. for PDE4 inhibitor, HPP737
February 2, 2026
·
7 min read
Press Releases
Co-Diagnostics Performs Analysis of Influenza Co-Primers® to Confirm Reactivity Against Flu A H3N2 Mutation
December 18, 2025
·
4 min read
Earnings
Novartis CEO Says Trump’s Drug Pricing Deals Don’t Address Root Problem
Vas Narasimhan confirmed that Novartis is having weekly discussions with the Trump administration on drug pricing, but a deal has not yet been reached.
October 28, 2025
·
3 min read
·
Annalee Armstrong
Press Releases
The European Commission extended the Marketing Authorisation for Vueway® (gadopiclenol) in the European Union for use in pediatric patients under 2 years of age
January 28, 2026
·
5 min read
Press Releases
Evogene and Shanghai Lishan Biopharmaceuticals Co. Announce Exclusive Licensing Agreement for BMC128, a Microbiome-Based Therapeutic for Renal and Lung Cancer
February 5, 2026
·
6 min read
1 of 84,286
Next
